About Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
CureVac
1
Clinical Trials at Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik
During the past decade, Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease
2009-01-01
2013-09-01
Completed
48
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
2014-05-31
2023-02-28
Completed
310
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
2015-01-13
2018-11-08
Completed
931
A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection
2015-10-05
2022-06-14
Completed
809
A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
2016-11-30
2022-12-12
Completed
1,005
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)
2014-05-31
2023-02-28
Completed
119
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
2017-01-03
2022-12-08
Completed
778
A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment
2020-07-28
2024-03-01
Active, not recruiting
522
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik"
#1 collaborator was "Chugai" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik
According to Clinical.Site data, the most researched conditions in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik" are
"Bladder Cancer" (3 trials), "Carcinoma, Renal Cell" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Hormonal Refractory Prostate Cancer" (1 trials) and "Muscle-invasive Bladder Cancer" (1 trials). Many other conditions were trialed in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik
Most popular intervention types in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (7 trials), "Placebo" (2 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "CV9103" (1 trials) and "Cabozantinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik
The vast majority of trials in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik" are
8 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik
Currently, there are NaN active trials in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".